The Pharmaceutical Project
Dicot is developing the candidate LIB-01 into a new modern potency drug for the world market. The ambition is to create a drug that has longer duration of action and fewer side effects than those available on the market today. This way, Dicot wants to drastically improve the treatment of erection problems and give affected men and couples a better intimate life. The goal is to make LIB-01 the first choice of treatment for erectile dysfunction and premature ejaculation.